MarketScreener Homepage > Equities > Nasdaq > Gilead Sciences, Inc. GILD

Report

Delayed Nasdaq - 10/30 04:00:00 pm
58.15	USD		-0.65%

10/29

GLOBAL MARKETS LIVE: Big names today

10/29

GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend

10/29

GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results

News

Official Publications

Sector news

MarketScreener Strategies

Analyst Recommendations

Sector news Bio Therapeutic Drugs

10/30	Lonza to make COVID-19 antibody combination for AstraZeneca	RE
10/30	REGENERON PHARMACEUTICALS : Trial of Covid-19 Antibody Drug Regeneron Is Halted ..	DJ
10/30	REGENERON PHARMACEUTICALS : Monitoring Committee for Covid-19 Vaccine Recommends..	DJ
10/30	REGENERON PHARMACEUTICALS : to stop enrolling very sick COVID-19 patients in ant..	RE
10/30	REGENERON PHARMACEUTICALS : REFILE-Regeneron to not enrol COVID-19 patients in n..	RE
10/30	BioNTech CEO expects data from late-stage study soon	RE
10/30	LONZA : to make COVID-19 antibody combination for AstraZeneca	RE
10/29	WUXI APPTEC : Third-Quarter Net Profit Fell on Higher Costs	DJ
10/29	BIONTECH : Germany Aims to Start Coronavirus Vaccination This Year -- Update	DJ
10/29	EU to fund transfer of COVID-19 patients across borders to prevent hospitals ..	RE
10/29	EU Commission says talking to four companies on COVID vaccine	RE
10/29	Fauci says first U.S. COVID-19 vaccines could ship late December or early Jan..	RE
10/29	BIONTECH : Germany Aims to Start Coronavirus Vaccination This Year	DJ
10/29	Sanofi Says It Won EU Patent Ruling Against Amgen Over Cholesterol Drug -- Up..	DJ
10/29	Moderna on track to report late-stage COVID-19 vaccine data next month	RE
10/29	Sanofi Says It Won EU Patent Ruling Against Amgen Over Cholesterol Drug	DJ
10/29	REGENERON PHARMACEUTICALS : Gets FDA Priority Review of Libtayo in Lung Cancer	DJ
10/29	Japan's Takeda to import 50 million doses of Moderna's COVID-19 vaccine, rais..	RE
10/29	Next crop of COVID-19 vaccine developers take more traditional route	RE
10/29	Britain expects verdict on Pfizer's COVID-19 vaccine before AstraZeneca's - T..	RE
10/28	REGENERON : Data Shows REGN-COV2 Reduced Virus Levels, Need for Further Medical ..	DJ
10/28	REGENERON PHARMACEUTICALS : says its COVID-19 antibody treatment cut medical vis..	RE
10/28	QIAGEN NV : JP Morgan maintains a Buy rating	MD
10/28	ASTRAZENECA : U.S. strikes deal with Lilly for potential COVID-19 antibody drug	RE
10/28	QIAGEN NV : Jefferies reiterates its Neutral rating	MD
10/27	ELI LILLY AND : Earnings, Halted Covid-19 Drug Trial Disappoint Investors -- Upd..	DJ
10/27	Pfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully Enrolled -- 3rd Up..	DJ
10/27	EU warns not enough COVID vaccines for all in Europe until 2022	RE
10/27	UK starts real-time review of Moderna's COVID-19 vaccine candidate	RE
10/27	Pfizer says no COVID-19 vaccine data yet, could be week or more before it rep..	RE
10/27	Pfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully Enrolled -- 2nd Up..	DJ
10/27	MODERNA : UK starts real-time review of Moderna's COVID-19 vaccine candidate	RE
10/27	EXACT SCIENCES : to buy cancer-screening firm Thrive Earlier Detection in $2.15 ..	RE
10/27	Pandemic Dents Third-Quarter Sales for Pfizer -- Update	DJ
10/27	Pfizer says no COVID-19 vaccine data yet, could be week or more before it rep..	RE
10/27	REGENERON PHARMACEUTICALS : Eli Lilly strikes optimistic tone on COVID-19 therap..	RE
10/27	S.Korea begins preliminary review of AstraZeneca's COVID-19 vaccine candidate	RE
10/26	S.Korea shares dip as surging global coronavirus cases dent sentiment	RE
10/26	South Korea pharma Celltrion's COVID test gets U.S. emergency use authorisati..	RE
10/25	S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation	RE
10/25	Qatar signs deal to buy Moderna COVID-19 vaccine	RE
10/23	Why Merck Is Playing Catch-Up in the Coronavirus Vaccine Chase	DJ
10/23	Canada to invest up to C$214 mln for research into domestic-made vaccines - P..	RE
10/23	MODERNA : Positive pre-clinical data for CureVac's COVID-19 vaccine	RE
10/23	QIAGEN NV : Independant Research remains a Sell rating	MD
10/22	Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a..	RE
10/22	PFIZER : How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race	DJ
10/22	Covid-19 Vaccine Makers to Face Challenges When Recognizing Revenue	DJ
10/22	Britain partners with Oxford firm to assess coronavirus vaccine T cell respon..	RE
10/21	Ecuador signs COVID-19 vaccine supply deals with pharma companies	RE

1 2 3 4 5 6 7 8 9 10 Next

Analysis

Gilead Sciences : cuts 2020 sales outlook as COVID-19 drug remdesivir falls short

MarketScreener Homepage > Equities > Nasdaq > Gilead Sciences, Inc. GILD

GILEAD SCIENCES, INC.